Literature DB >> 34907906

Dietary sugar restriction reduces hepatic de novo lipogenesis in boys with fatty liver disease.

Stephanie T Chung1, Sheela N Magge2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) in children resulting from the obesity epidemic is widespread and increasing. Although the complexities of pediatric NAFLD are recognized, screening and therapies in children remain limited. Moreover, pediatric NAFLD diagnosis fails to consider insulin resistance and metabolic dysfunction as important determinants. In this issue of the JCI, Cohen et al. explored the contribution of dietary factors to the pathogenesis of NAFLD in adolescent boys with biopsy-proven NAFLD and control participants. Notably, dietary sugar restriction over 8 weeks decreased de novo lipogenesis (DNL) and hepatic fat. The change in DNL correlated with changes in insulin and weight, but not with changes in hepatic fat, supporting the relevance of metabolic dysfunction to NAFLD. These results confirm the pathological link between excessive dietary sugar intake and NAFLD in children and support recent recommendations to change the nomenclature of NAFLD to metabolic associated fatty liver disease (MAFLD).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34907906      PMCID: PMC8670863          DOI: 10.1172/JCI154645

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents.

Authors:  S Wiegand; K-M Keller; M Röbl; D L'Allemand; T Reinehr; K Widhalm; R W Holl
Journal:  Int J Obes (Lond)       Date:  2010-06-08       Impact factor: 5.095

2.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

3.  Intrahepatic fat, irrespective of ethnicity, is associated with reduced endogenous insulin clearance and hepatic insulin resistance in obese youths: A cross-sectional and longitudinal study from the Yale Pediatric NAFLD cohort.

Authors:  Domenico Tricò; Alfonso Galderisi; Andrea Mari; David Polidori; Brittany Galuppo; Bridget Pierpont; Stephanie Samuels; Nicola Santoro; Sonia Caprio
Journal:  Diabetes Obes Metab       Date:  2020-05-31       Impact factor: 6.577

4.  [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].

Authors:  Xin Zhou; Dong-qing Hou; Jia-li Duan; Ying Sun; Hong Cheng; Xiao-yuan Zhao; Jun-ting Liu; Ping Yang; Xin-ying Shan; Jie Mi
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2013-05

Review 5.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

6.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

7.  Free fatty acid processing diverges in human pathologic insulin resistance conditions.

Authors:  Hilal Sekizkardes; Stephanie Therese Chung; Shaji Chacko; Morey W Haymond; Megan Startzell; Mary Walter; Peter J Walter; Marissa Lightbourne; Rebecca J Brown
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 8.  Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement.

Authors:  Mohammed Eslam; Naim Alkhouri; Pietro Vajro; Ulrich Baumann; Ram Weiss; Piotr Socha; Claude Marcus; Way Seah Lee; Deirdre Kelly; Gilda Porta; Mohamed A El-Guindi; Anna Alisi; Jake P Mann; Nezha Mouane; Louise A Baur; Anil Dhawan; Jacob George
Journal:  Lancet Gastroenterol Hepatol       Date:  2021-08-05

9.  Triglyceride Paradox Is Related to Lipoprotein Size, Visceral Adiposity and Stearoyl-CoA Desaturase Activity in Black Versus White Women.

Authors:  Stephanie T Chung; Celeste K L Cravalho; Abby G Meyers; Amber B Courville; Shanna Yang; Nirupa Rachel Matthan; Lilian Mabundo; Maureen Sampson; Ronald Ouwerkerk; Ahmed M Gharib; Alice H Lichtenstein; Alan T Remaley; Anne E Sumner
Journal:  Circ Res       Date:  2019-10-18       Impact factor: 17.367

10.  Hepatic fat is a stronger correlate of key clinical and molecular abnormalities than visceral and abdominal subcutaneous fat in youth.

Authors:  Catherine E Cioffi; K M Venkat Narayan; Ken Liu; Karan Uppal; Dean P Jones; ViLinh Tran; Tianwei Yu; Jessica A Alvarez; Moriah P Bellissimo; Kristal M Maner-Smith; Bridget Pierpoint; Sonia Caprio; Nicola Santoro; Miriam B Vos
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07
View more
  1 in total

Review 1.  Dietary Assessment Tools and Metabolic Syndrome: Is It Time to Change the Focus?

Authors:  Helen Chauhan; Regina Belski; Eleanor Bryant; Matthew Cooke
Journal:  Nutrients       Date:  2022-04-08       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.